Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis

• Main Authors: Yi Yang (Author), Gang Jin (Author), Yao Pang (Author), Yijie Huang (Author), Wenhao Wang (Author), Hongyi Zhang (Author), Guangxin Tuo (Author), Peng Wu (Author), Zequan Wang (Author), Zijiang Zhu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundCombination therapy with immune checkpoint inhibitors (ICIs) has been applied in the clinic to achieve synergistic effects and to improve clinical efficacy. Compared with monotherapy, combination therapy has promising efficacy against various advanced cancers. To further verify the effecti...